Racheli is a Chemistry and Biotechnology Engineer with extensive experience in the Biotech industry in various managerial positions. She served as the COO at AIT Therapeutic Inc. (OTC:AITB) since its inception. AIT is an Israeli biopharmaceutical company that develops a drug device combination for treating respiratory infections. Prior to AIT she served as director of regulatory affairs and quality assurance at Sharplight Tech. Ltd and as a senior director of regulatory affairs and quality assurance at Rosetta Genomics (Nasdaq: ROSG).
She has an extensive experience in management, product development, dealing with complicated operations, raising funds and business development.
My mission is to save women’s lives from breast cancer by empowering the communities to support better diagnostics and therapeutic tools.
I can help the foundation in raising support from the community, get access to clinical data as well as access to new technological developments.